Home / TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA)

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Technical Analysis

Updated: 2026-06-16 09:35 UTC · Last close: 33.69 (-2.71%) · Support: 33.55 · Resistance: 36.34
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⬇️ Support
33.55
⬆️ Resistance
36.34
⚠️ Risk Line
losing 33.55 would weaken the current structure.
🔺 Technical Setup
Breakout Watch
Downtrend line not broken yet · score 0
Watch Level
36.85
RSI(14)
47.9
🎯 Decision Map
From a roadmap perspective, the setup is boxed by support near 33.55 and resistance around 36.85. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
📊 Technical Summary
At a glance
Trend
Constructive
Momentum
Neutral
Range
87% of 52W range
Key Zone
33.55 / 36.34
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) finished the session at 33.69 (-2.71%). Trend remains constructive above MA50 and MA200. Momentum: -1.75%; 52W position: 87% of range; and Volatility: ATR14 3.81%. RSI(14) stands around 47.9, which keeps the momentum picture broadly balanced. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram is negative and weakening further, which reflects continued downside pressure.
🎯
Key levels: The most important nearby levels are support at 33.55 and resistance at 36.34.
🚀
Trigger: Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup.
💼 Fundamentals Snapshot
Source: sec
💼 Business Lens
QUALITY VIEW
Financial quality snapshot
Financial context is mixed
📈 Growth: Moderate 💰 Profit: Improving 💵 Cash: Pressured 🛡 Balance: Stretched
• Quarterly revenue is still growing, but the pace is cooling from earlier highs.
• Quarterly profitability is improving as earnings recover from an earlier soft patch.
💵 Revenue
3.98B
📈 Net Income
369.00M
🧮 EPS (Basic)
0.32
🏢 Company
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
🏷 Sector
Healthcare
🧩 Industry
Pharma
Compare with related stocks
Same sector and industry ideas for deeper research
AbbVie (ABBV) technical analysisAstrazeneca (AZN) technical analysisBristol-Myers Squibb Company (BMY) technical analysisJohnson & Johnson (JNJ) technical analysisELI LILLY & Co (LLY) technical analysisMerck & Co (MRK) technical analysisPfizer (PFE) technical analysis
WOI OPEN ADVANCED ANALYSIS WORKSPACE
Note: This is an algorithmic technical snapshot (not financial advice).
TEVA Chart